None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Women over the age of 19 (2) Subjects who have consented to the provision of samples for human-derived materials (3) Subjects who voluntarily consented to this study and filled out the consent form (4) Those who can be followed up during the test period
Exclusion criteria
Exclusion criteria: (1) Subjects with accompanying skin diseases (atopic dermatitis, psoriasis, acne, etc.) (2) Subjects who have taken systemic antibiotics or antifungals within six months (3) Subjects who have used topical agents (steroids, antibiotics, antifungals, etc.) within seven days at the site to be tested (4) Patients with systemic conditions accompanied by instability of vital signs such as infection or organ failure (5) Those who show skin damage or local infection at the measurement site (6) Subjects who did not consent to the provision of human-derived specimens (7) Subjects who did not voluntarily consent to this study and did not fill out the consent form (8) Vulnerable subjects (including persons with disabilities, insufficient medical ability, pregnant women, newborns, minors, staff in the research department's department, persons confined in facilities, etc.) (9) Subjects who cannot read and understand the consent form (illiteracy, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the relationship between the skin microbiome distribution and the phenotype of skin aging | — |
Secondary
| Measure | Time frame |
|---|---|
| skin biophysical parameters | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital